O165 SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL-RESPONDER/TREATMENT-NAIVE PATIENTS (COSMOS STUDY): PRIMARY ENDPOINT (SVR12) RESULTS IN PATIENTS WITH METAVIR F3–4 (COHORT 2)
Authors:
- E. LawitzELE. Lawitz
- R. GhalibRGR. Ghalib
- M. Rodriguez-TorresMRM. Rodriguez-Torres
- Z.M. YounossiZYZ.M. Younossi
- A. CorregidorACA. Corregidor
- M.S. SulkowskiMSM.S. Sulkowski
- E. DeJesusEDE. DeJesus
- B. PearlmanBPB. Pearlman
- M. RabinovitzMRM. Rabinovitz
- N. GitlinNGN. Gitlin
- J.K. LimJLJ.K. Lim
- P.J. PockrosPPP.J. Pockros
- 1 April 2014
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S524